Acrux heads to the Finnish

By Dylan Bushell-Embling
Thursday, 14 August, 2008

Acrux [ASX: ACR] has entered into a manufacturing alliance with the Finnish Orion Corporation.

Under the agreement, Orion will become the exclusive manufacturer for Acrux's Testosterone MD-Lotion, as well as a range of transdermal spray products under development.

Acrux retains the rights to supply the products to licensees in all territories.

Both parties will invest in additional equipment at Orion's manufacturing facility as part of the alliance.

Scientists search for cystitis pain 'off switch'

By targeting certain pain receptors in the bladder, Australian scientists believe that the...

Australia's first cases of H5 avian influenza confirmed

Positive results for H5 avian influenza (bird flu) have been confirmed in two seabirds found in...

AusBiotech partners with Tenmile

Designed to support Australia's homegrown life sciences innovation, AusBiotech has announced...

Content from other channels on our network

Daniel Wyner appointed Lumary CEO

Home care safeguards when disasters hit

"Historic legislation" allows authorised nurses to prescribe PBS medicines

You see what others miss

Tapping into the labour mobility market to fill ongoing workforce gaps

Nestlé launches on-pack date-labelling pilot to help tackle food waste

Handling the protein powder boom: engineering solutions for powder processing

Seafood safety researcher awarded at NZIFST Food Industry Awards

Blade innovation reduces the cost of slicing and dicing

Hygienic Design in Practice: Supporting Modern Food Production

Energy crisis will have long‍-‍term effects: Australian Industry Group

Myriota launches hybrid 5G satellite and cellular IoT network

Funding program for smaller businesses to access additive manufacturing

Collaboration provides NZ's largest smart water meter upgrade

ARENA backs Sicona battery technology to boost EV performance